[go: up one dir, main page]

GB0226275D0 - Method of treatment - Google Patents

Method of treatment

Info

Publication number
GB0226275D0
GB0226275D0 GB0226275A GB0226275A GB0226275D0 GB 0226275 D0 GB0226275 D0 GB 0226275D0 GB 0226275 A GB0226275 A GB 0226275A GB 0226275 A GB0226275 A GB 0226275A GB 0226275 D0 GB0226275 D0 GB 0226275D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0226275A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Royal Veterinary College
Original Assignee
Royal Veterinary College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal Veterinary College filed Critical Royal Veterinary College
Priority to GB0226275A priority Critical patent/GB0226275D0/en
Publication of GB0226275D0 publication Critical patent/GB0226275D0/en
Priority to ARP030103236A priority patent/AR047712A1/en
Priority to ES03793917T priority patent/ES2304541T3/en
Priority to CA2538187A priority patent/CA2538187C/en
Priority to US10/526,753 priority patent/US8178084B2/en
Priority to AU2003263340A priority patent/AU2003263340B2/en
Priority to DE60319848T priority patent/DE60319848T2/en
Priority to DE60335752T priority patent/DE60335752D1/de
Priority to AT03793917T priority patent/ATE389412T1/en
Priority to EP03793917A priority patent/EP1545567B1/en
Priority to PCT/GB2003/003894 priority patent/WO2004022078A1/en
Priority to EP10186184A priority patent/EP2316462A1/en
Priority to EP07014066A priority patent/EP1872789B1/en
Priority to AT07014066T priority patent/ATE494898T1/en
Priority to NZ539308A priority patent/NZ539308A/en
Priority to US13/471,517 priority patent/US20120230960A1/en
Priority to US13/551,051 priority patent/US20130039896A1/en
Priority to US14/487,660 priority patent/US20150017145A1/en
Priority to US15/442,590 priority patent/US20170258848A1/en
Ceased legal-status Critical Current

Links

GB0226275A 2002-09-07 2002-11-12 Method of treatment Ceased GB0226275D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GB0226275A GB0226275D0 (en) 2002-11-12 2002-11-12 Method of treatment
ARP030103236A AR047712A1 (en) 2002-09-07 2003-09-05 TREATMENT METHOD OF A NATURAL SOFT SKELETTIC TISSUE INJURY MANAGING A COMPOSITION OF MESENQUIMATOSE MOTHER CELLS
NZ539308A NZ539308A (en) 2002-09-07 2003-09-08 Pharmaceutical kits comprising mesenchymal stem cells
AT03793917T ATE389412T1 (en) 2002-09-07 2003-09-08 MEDICATION WITH MESENCHYME STEM CELLS
EP10186184A EP2316462A1 (en) 2002-09-07 2003-09-08 Pharmaceutical kits comprising mesenchymal stem cells
US10/526,753 US8178084B2 (en) 2002-09-07 2003-09-08 Pharmaceutical kits comprising mesenchymal stem cells
AU2003263340A AU2003263340B2 (en) 2002-09-07 2003-09-08 Pharmaceutical kits comprising mesenchymal stem cells
DE60319848T DE60319848T2 (en) 2002-09-07 2003-09-08 Drug with mesenchymal stem cells
DE60335752T DE60335752D1 (en) 2002-09-07 2003-09-08
ES03793917T ES2304541T3 (en) 2002-09-07 2003-09-08 MEDICATION THAT INCLUDES MESENQUIMAL MOTHER CELLS.
EP03793917A EP1545567B1 (en) 2002-09-07 2003-09-08 Medicament comprising mesenchymal stem cells
PCT/GB2003/003894 WO2004022078A1 (en) 2002-09-07 2003-09-08 Pharmaceutical kits comprising mesenchymal stem cells
CA2538187A CA2538187C (en) 2002-09-07 2003-09-08 Pharmaceutical kits comprising mesenchymal stem cells
EP07014066A EP1872789B1 (en) 2002-09-07 2003-09-08 Compositions comprising mesenchymals stem cells
AT07014066T ATE494898T1 (en) 2002-09-07 2003-09-08 COMPOSITIONS WITH MESENCHYMEL STEM CELLS
US13/471,517 US20120230960A1 (en) 2002-09-07 2012-05-15 Pharmaceutical kits comprising mesenchymal stem cells
US13/551,051 US20130039896A1 (en) 2002-09-07 2012-07-17 Pharmaceutical kits comprising mesenchymal stem cells
US14/487,660 US20150017145A1 (en) 2002-09-07 2014-09-16 Pharmaceutical Kits Comprising Mesenchymal Stem Cells
US15/442,590 US20170258848A1 (en) 2002-09-07 2017-02-24 Pharmaceutical Kits Comprising Mesenchymal Stem Cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0226275A GB0226275D0 (en) 2002-11-12 2002-11-12 Method of treatment

Publications (1)

Publication Number Publication Date
GB0226275D0 true GB0226275D0 (en) 2002-12-18

Family

ID=9947604

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0226275A Ceased GB0226275D0 (en) 2002-09-07 2002-11-12 Method of treatment

Country Status (1)

Country Link
GB (1) GB0226275D0 (en)

Similar Documents

Publication Publication Date Title
GB2393202B (en) Methods of well treatment
AU2003226301A8 (en) Method of treating cancer
AU2003278361A1 (en) Method of water treatment
AU2003256847A8 (en) Method of treating cancer
IL164266A0 (en) Treatment of gastroparesis
EP1577280A4 (en) Method of deuterization
IL165304A0 (en) Method of treating diabetes
GB0302572D0 (en) Method of treatment
GB0306309D0 (en) Method of treatment
GB0124124D0 (en) Methods of treatment
EP1493716A4 (en) Method of wastewater treatment
GB0112216D0 (en) Method of treatment
PL376350A1 (en) Sludge treatment method
GB0208897D0 (en) New method of treatment
GB0118892D0 (en) Method of treatment
AU2003252188A8 (en) Method of ore treatment
GB0217493D0 (en) Novel methods of treatment
AU2002951913A0 (en) Method of treatment
GB0221712D0 (en) Methods of treatment
GB0213198D0 (en) Method of treatment
GB0307544D0 (en) Treatment method
GB0327975D0 (en) Methods of treatment
GB0207091D0 (en) Method of treatment
GB0206699D0 (en) Method of treatment
GB0215583D0 (en) Method of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)